Target intelligence / Profile preview

Cyclic nucleotide-binding domain-containing protein 1 (CNBD1)

Target
CNBD1
Molecular classification
Other (contains cyclic nucleotide-binding domain, but is not classified as receptor, ion channel, enzyme, or transcription factor in major databases)
01

Overview

Cyclic nucleotide-binding domain-containing protein 1 (CNBD1) is a human protein characterized by the presence of a cyclic nucleotide-binding domain, a structural motif known for binding signaling molecules such as cAMP and cGMP. While many proteins with this domain are involved in signal transduction (like kinases and ion channels), CNBD1 itself has no characterized biological function or disease association as of current research and protein annotation databases. It is typically considered within the broader family of cyclic nucleotide-binding proteins but is not a clinically validated therapeutic target. The domain structure suggests potential for cyclic nucleotide interaction, though specific ligands, biological roles, and clinical relevance remain undefined. Additional context: - The cyclic nucleotide-binding domain is common in critical proteins, including protein kinases and certain ion channels; however, CNBD1's individual role is not delineated. - Other proteins with this domain, such as cAMP-dependent protein kinase (PKA), are well studied and implicated in diseases, but CNBD1 is not currently included among these functional targets. If you need information on structurally or functionally related targets (such as cAMP-dependent protein kinase or cyclic nucleotide-gated channels), many have established clinical, biological, and pharmacological significance. CNBD1 itself remains an uncharacterized protein with inferred general function from domain analysis.

Other names
Cyclic nucleotide-binding domain-containing protein 1CNBD1
02

Mechanism of action

Not applicable; mechanisms of drug action are not established for CNBD1

03

Biological functions

Unknown; its specific biological role in humans is not well characterizedGeneral protein binding to cyclic nucleotides (by domain inference)
04

Disease associations

Unknown; there are no established disease associations or clinical roles as per major databases and current literature
05

Safety considerations

None documented as related to CNBD1 targeting or modulation
06

Interacting drugs

None known; no drugs are listed that directly interact with CNBD1
07

Biomarkers

None reported for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Cyclic nucleotide-binding domain-containing protein 1 (CNBD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclic nucleotide-binding domain-containing protein 1 (CNBD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call